Back to the program

Topic-Contributed Paper Session

Recent Developments for the Evaluation of Overall Survival in Clinical Trials in Chronic or Indolent Cancers

Tue, Aug 6, 2:00 PM - 3:50 PM

Lisa HampsonChairQi JiangOrganizerRajeshwari SridharaOrganizerEmmanuel ZuberOrganizer

Biopharmaceutical Section

3 Presentations

Monitoring guidelines for overall survival in pivotal trials in indolent cancers

2:05 PM - 2:25 PM

Thomas Fleming (University of Washington)

Pre-Specified Safety Analysis of OS Data for Trials in Indolent or Early-Stage Cancers

2:25 PM - 2:45 PM

Preventing Harm: Approaches for monitoring OS in randomized oncology trials

2:45 PM - 3:05 PM

Discussant

Tim Friede (University Medical Center Goettingen)

↑